Status:
NOT_YET_RECRUITING
Collection of Additional Biological Samples From Potentially COVID-19 Patients for Monitoring of Biological Parameters Carried Out as Part of the Routine
Lead Sponsor:
CerbaXpert
Conditions:
SARS CoV 2 Infection
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Patients infected with SARS-CoV-2 can present with a wide range of manifestations clinical conditions, ranging from no symptoms to serious or chronic illness. The current gold standard test for the di...
Eligibility Criteria
Inclusion
- Patient over 18 years old
- Patient coming for a biological analysis as part of the care for prevention, screening or monitoring of the pathogen target
- Patient able to understand the information note and give a free and informed consent, on paper or digital media
- Clinical patients:
- Control cases (all comers or ambulatory)
- Known positive for the pathology concerned
- Patient hospitalized for the pathology concerned
- Pregnant or breastfeeding patient
- Dialysis patient
Exclusion
- Patient already included in a research protocol
- Patient having received medication or treatment experimental or investigational during the last four weeks before collection
- Patient subject to a legal protection measure
- Patient affiliated with state medical aid (AME)
- Patient not affiliated to the compulsory Social Security system
- Refusal or inability to provide signed informed consent
- According to the investigator, the patient is not eligible for inclusion in the study
Key Trial Info
Start Date :
December 23 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 23 2026
Estimated Enrollment :
7500 Patients enrolled
Trial Details
Trial ID
NCT06144333
Start Date
December 23 2024
End Date
November 23 2026
Last Update
April 15 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.